December 22, 2025 09:57 am (IST)
Emerging markets affect Dr Reddy's Laboratories' December quarter performance
Hyderabad, Feb 9 (IBNS) Dr Reddy's Laboratories Ltd announced its consolidated financial results on Tuesday for the quarter ended December 31, 2015, where it posted consolidated revenue of ₹39.7 billion, up 3 per cent from the same period in 2014, largely because the healthy performance in North America Generics (NAG), Europe and India were partially offset by emerging markets, which were impacted by unfavorable macro-economic conditions.
Revenues from the Global Generics segment for the reported quarter was ₹33.6 billion, up 7 per cent from the year-ago quarter, primarily driven by North America, Europe and India.
Revenues from the Pharmaceutical Services and Active Ingredients (PSAI) segment was ₹5.1 billion in the reported quarter, and declined by 17 per cent from the same quarter a year ago.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Reject Macaulayan education, reclaim Indian values: H M Bangur’s big World Hindu Economic Forum pitch
Sat, Dec 20 2025
Big Global Push! Bank of Baroda Backs $500 Million Foreign Currency Loan for OVL’s Overseas Arm
Sat, Dec 20 2025
Big move in luxury retail! Helios Luxe introduces legendary Auguste Reymond to India
Sat, Dec 20 2025
Tata AIA launches multicap opportunities fund
Fri, Dec 19 2025
IPO fireworks! ICICI Prudential AMC pops 20% on market debut
Fri, Dec 19 2025
Bharti Airtel announces top leadership changes; Gopal Vittal to become Executive Vice Chairman
Thu, Dec 18 2025
TCS bets big on AI, shares spike as company reveals ambitious plan
Thu, Dec 18 2025
Meesho’s wild ride: Hits record market cap, then suddenly slides
Thu, Dec 18 2025
